Market revenue in 2020 | USD 122.4 million |
Market revenue in 2028 | USD 226.9 million |
Growth rate | 8% (CAGR from 2020 to 2028) |
Largest segment | External beam radiationtherapy |
Fastest growing segment | Internal Beam Radiation Therapy |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
External beam radiationtherapy was the largest segment with a revenue share of 82.35% in 2020. Horizon Databook has segmented the India radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
The radiation oncology market in India is expected to exhibit a lucrative growth over the forecast period, owing to increasing incidence of cancer and focus on improving patient access to treatments. Radiation therapy in India is mainly offered by the private sector.
The market is growing and presents a major opportunity. Investments in the public sector are expected to increase over the forecast period. According to an article published in Indian Journal of Cancer in 2019.
The utilization rate of radiotherapy in India is greater than 55% and is expected to reach 70% to 80% in some types of cancer. Approximately 800,000 patients need radiotherapy every year in India. Currently, India has nearly 365 medical accelerators, 8 Tomo therapy machines.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account